Research Article
Expression of CD47 in Endometrial Cancer and Its Clinicopathological Significance
Table 6
Screening of prognosticators in EC patients with univariate and multivariate analysis.
| Characteristics | n | HR (95% CI) univariate analysis | P value univariate analysis | HR (95% CI) multivariate analysis | P value multivariate analysis |
| Age | 344 | 1.066 (1.026–1.108) | <0.001 | 1.031 (0.984–1.080) | 0.201 | CD47 (positive vs. negative) | 344 | 0.438 (0.218–0.881) | 0.021 | 0.754 (0.349–1.630) | 0.473 | Cancer type (I vs. II) | 344 | 10.275 (5.011–21.070) | <0.001 | 1.928 (0.629–5.907) | 0.251 | Clinical stage (I and II vs. III and IV) | 344 | 3.907 (2.714–5.625) | <0.001 | 2.410 (1.280–4.535) | 0.006 | Histological grade (G3 vs. G1 and G2) | 344 | 2.491 (1.756–3.532) | <0.001 | 0.861 (0.463–1.601) | 0.636 | Infiltration depth (<1/2 vs. >1/2) | 344 | 4.533 (2.250–9.131) | <0.001 | 0.432 (0.129–1.438) | 0.171 | P53 (mutant vs. wild type) | 344 | 0.777 (0.349–1.733) | 0.538 | | | Ki67 (>50% vs. <50%) | 344 | 2.244 (1.094–4.603) | 0.028 | 1.218 (0.545–2.719) | 0.631 | Lymph node metastasis (yes vs. no) | 344 | 13.845 (6.872–27.894) | <0.001 | 4.675 (1.358–16.096) | 0.015 |
|
|